BIOA Latest Headlines

BioAge Moves BGE-102 Into Mid-Stage Obesity Heart-Risk Trial, Raising New Investor Focus

at www.tipranks.com (Thu, 18-Jun 12:32 PM)

Analysts Are Bullish on These Healthcare Stocks: BioAge Labs, Inc. (BIOA), Karyopharm Therapeutics (KPTI)

at www.tipranks.com (Wed, 17-Jun 9:30 AM)

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN)

at www.tipranks.com (Wed, 17-Jun 7:00 AM)

BioAge’s BGE-102 Achieves Over 85% Reduction in hsCRP, Setting New Benchmark in Inflammation Trials

Market Chameleon (Tue, 21-Apr 7:35 AM)

BioAge Labs Highlights Progress in Metabolic Aging Therapeutics Ahead of Needham Conference Presentation

Market Chameleon (Tue, 14-Apr 9:22 AM)